1.8PLN
4.20 MPLN
95.56 MPLN
About BIOGENED
Sector
CEO
Andrzej Rafal Grzegorzewski
Headquarters
Lodz
Website
Employees (FY)
205
Founded
1949
ISIN
PLBIOGN00018
FIGI
BBG001Z52905
Biogened SA engages in the production and distribution of pharmaceutical products and cosmetics. It operates under the brand name Dermedic. The firm also engages in the research and development in the area of dermatology. The company was founded in 1949 and is headquartered in Lodz, Poland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BGD is 24.8 PLN — it has decreased by 3.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange BIOGENED stocks are traded under the ticker BGD.
BGD stock is 7.50% volatile and has beta coefficient of −0.22. Check out the list of the most volatile stocks — is BIOGENED there?
Yes, you can track BIOGENED financials in yearly and quarterly reports right on TradingView.
BGD stock has fallen by 6.06% compared to the previous week, the month change is a 14.48% fall, over the last year BIOGENED has showed a 79.71% increase.
BGD net income for the last quarter is 141.06 K PLN, while the quarter before that showed 591.50 K PLN of net income which accounts for −76.15% change. Track more BIOGENED financial stats to get the full picture.
Yes, BGD dividends are paid annually. The last dividend per share was 0.40 PLN. As of today, Dividend Yield (TTM)% is 1.55%. Tracking BIOGENED dividends might help you take more informed decisions.
Like other stocks, BGD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOGENED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 205.00 employees. See our rating of the largest employees — is BIOGENED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOGENED technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOGENED stock shows the buy signal. See more of BIOGENED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOGENED EBITDA is 12.13 M PLN, and current EBITDA margin is 12.70%. See more stats in BIOGENED financial statements.